EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Plasma IL-22 and Claudin-4 in obstructive sleep apnea: A pilot observational study linking mucosal barrier biomarkers to disease severity

Dan Liu, Yan Wang, Zhiding Wang, Jing Feng

Sleep Medicine · 2025-09 · 133 · 106641

DOI: 10.1016/j.sleep.2025.106641 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Sleep Medicine, 2025-09. Verfasst von Dan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Interleukins, Claudin-4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Obstructive sleep apnea (OSA) is characterized as a low-grade inflammatory condition resulting from injury induced by intermittent hypoxia (IH). Interleukin-22 (IL-22), a mucosa-targeting cytokine, regulates tight junction proteins like Claudin-4 (CLDN4) to enhance barrier function, yet its role in OSA remains underexplored. METHODS: This pilot observational study included consecutive patients who underwent polysomnography. Plasma IL-22 and CLDN4 levels were measured using an enzyme-linked immunosorbent assay. Rat models of IH-exposed colon tissues were used for histology and immunohistochemical analysis. All statistical analyses were performed using SPSS 20.0. RESULTS: The expression of plasma IL-22 and CLDN4 was found to be positively correlated in OSA patients (r = 0.512, p < 0.001). Plasma IL-22 and CLDN4 levels exhibited a significant positive correlation with the apnea-hypopnea index (both p < 0.001), arousal index (p = 0.001 and p = 0.014), oxygen desaturation index (p < 0.001 and p = 0.001), and T90 (r = 0.379, p < 0.001 and p = 0.002). They also exhibited significant negative correlations with sleep efficiency (0.029; p = 0.004), REM sleep phases (p = 0.037 and p = 0.015), and mean oxygen saturation (SpO2) (p = 0.044 and p = 0.006). Plasma IL-22 and CLDN4 were significantly increased in the OSA group (p < 0.001), especially in severe OSA. The diagnostic value of plasma IL-22 combined with CLDN4 was superior to that of other indicators, with an AUC of 0.849 (0.783-0.915) for diagnosing OSA and an AUC of 0.909 (0.856-0.961) for diagnosing severe OSA. Pathological staining of the rat colon confirmed the damage of intermittent hypoxia (IH) to the intestine. The rat IH group had more IL-22 in the intestinal lymph node and more CLDN4 in the intestinal epithelium than the normal control (NC) group. The expression trends of IL-22 and CLDN4 in rat plasma were consistent with those observed in tissue samples. CONCLUSION: Plasma IL-22 and CLDN4 were associated with OSA severity and mucosal barrier alterations. Their co-regulation aligns with preclinical models of IH-driven barrier adaptation, supporting further mechanistic investigation. The diagnostic potential of the IL-22 +CLDN4 panel warrants validation in larger patient cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveInterleukinsClaudin-4Interleukin-22Pilot ProjectsHumansMaleBiomarkersFemaleMiddle AgedAnimalsPolysomnographySeverity of Illness IndexRatsAdultHypoxia

Stichwörter der Autor:innen

Claudin-4IL-22Intestinal repairObstructive sleep apnea

Substanzen

Interleukin-22InterleukinsBiomarkersClaudin-4

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China.
  • Beijing Institute of Basic Medical Sciences, Beijing, 100850, China. Electronic address: wzdfjfn@126.com.
  • Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China. Electronic address: jingfeng_zyy@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, D., Wang, Y., Wang, Z., & Feng, J. (2025). Plasma IL-22 and Claudin-4 in obstructive sleep apnea: A pilot observational study linking mucosal barrier biomarkers to disease severity. Sleep Medicine, 133, 106641. https://doi.org/10.1016/j.sleep.2025.106641

Vancouver

Liu D, Wang Y, Wang Z, Feng J. Plasma IL-22 and Claudin-4 in obstructive sleep apnea: A pilot observational study linking mucosal barrier biomarkers to disease severity. Sleep Medicine. 2025;133:106641. doi:10.1016/j.sleep.2025.106641

BibTeX
@article{Liu2025,
  author = {Liu, Dan and Wang, Yan and Wang, Zhiding and Feng, Jing},
  title = {Plasma IL-22 and Claudin-4 in obstructive sleep apnea: A pilot observational study linking mucosal barrier biomarkers to disease severity},
  journal = {Sleep Medicine},
  year = {2025},
  volume = {133},
  pages = {106641},
  doi = {10.1016/j.sleep.2025.106641}
}
Kostenlos starten →